The reported issue was confirmed.The device was returned for evaluation.Visual inspection of the returned sample noted 3 unopened (inside original packaging), bulb irrigation syringes.Visual inspection of the samples noted several pieces of foreign material.One of the samples had a black piece of foreign material measuring 0.20 sq mm inside the packaging (but loose outside the device).This was within specification, which states, "loose foreign matter or embedded shall not exceed an aggregate total of 0.6mm² or 1/16¿." the second sample had a black fibrous material measuring 0.0695 inches inside the packaging (but loose outside the device).The third sample had hair inside the packaging (but loose outside the device).These two samples were out of specification, which stated, "loose foreign matter or embedded shall not exceed an aggregate total of 0.6mm² or 1/16¿ and "no hair on product is permitted." although the reported event was confirmed, the root cause could not be determined.A potential root cause for this failure could be, ¿no follow up to the production areas cleaning procedure.¿ the device history record was reviewed and found nothing that could have caused or contributed to the reported event.The instructions for use were found adequate and state the following: ¿repackaging may create a risk of patient or user infection, compromise the structural integrity and/or essential material and design characteristics of the device, which may lead to device failure, and/or lead to injury, illness or death of the patient.Single use: contains or presence of phthalates (dehp); contains or presence of phthalates: di(2-ethylhexyl)phthalate (dehp) is a plasticizer used in some polyvinyl chloride medical devices.Dehp has been shown to produce a range of adverse effects in experimental animals, notably liver toxicity and testicular atrophy.Although the toxic and carcinogenic effects of dehp have been well established in experimental animals, the ability of this compound to produce adverse effects in humans is controversial.There is no evidence that neonates, infants, pregnant and breast feeding women exposed to dehp experience any related adverse effects.However, a lack of evidence of causation between dehp-pvc and any disease or adverse effect does not mean that there are no risks." h11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|